In HNSCC, high expression of SLC1A5 is associated with reduced CD8+ T cell infiltration, suggesting that SLC1A5 may suppress tumor immunity by modulating glutamine metabolism.214. This evidence concerns the gene SLC1A5 and head and neck squamous cell carcinoma.